Article

Late dysphagia after radiotherapy-based treatment of head and neck cancer

Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas. .
Cancer (Impact Factor: 4.9). 12/2012; 118(23):5793-9. DOI: 10.1002/cncr.27631
Source: PubMed

ABSTRACT Changing trends in head and neck cancer (HNC) merit an understanding of the late effects of therapy, but few studies examine dysphagia beyond 2 years of treatment.
A case series was examined to describe the pathophysiology and outcomes in dysphagic HNC survivors referred for modified barium swallow (MBS) studies ≥5 years after definitive radiotherapy or chemoradiotherapy (January 2001 through May 2011). Functional measures included the penetration-aspiration scale (PAS), performance status scale-head and neck (PSS-HN), National Institutes of Health Swallowing Safety Scale (NIH-SSS), and MBS impairment profile (MBSImp).
Twenty-nine patients previously treated with radiotherapy (38%) or chemoradiotherapy (62%) were included (median years posttreatment, 9; range, 5-19). The majority (86%) had oropharyngeal cancer; 52% were never-smokers. Seventy-five percent had T2 or T3 tumors; 52% were N+. The median age at diagnosis was 55 (range, 38-72). Abnormal late examination findings included: dysarthria/dysphonia (76%), cranial neuropathy (48%), trismus (38%), and radionecrosis (10%). MBS studies confirmed pharyngeal residue and aspiration in all dysphagic cases owing to physiologic impairment (median PAS, 8; median NIH-SSS, 10; median MBSImp, 18), whereas stricture was confirmed endoscopically in 7 (24%). Twenty-five (86%) developed pneumonia, half requiring hospitalization. Swallow postures/strategies helped 69% of cases, but no patient achieved durable improvement across functional measures at last follow-up. Ultimately, 19 (66%) were gastrostomy-dependent.
Although functional organ preservation is commonly achieved, severe dysphagia represents a challenging late effect that may develop or progress years after radiation-based therapy for HNC. These data suggest that novel approaches are needed to minimize and better address this complication that is commonly refractory to many standard dysphagia therapies. Cancer 2012. © 2012 American Cancer Society.

Download full-text

Full-text

Available from: Chris Holsinger, Nov 02, 2014
1 Follower
 · 
90 Views
  • [Show abstract] [Hide abstract]
    ABSTRACT: BACKGROUND: We analyzed published dose-volume data of the structures related to late radiotherapy-induced swallowing disturbances in head-and-neck cancer to estimate their sensitivity, specificity, and predictive value and to propose minimal criteria for future studies. METHODS: We performed a systematic literature search to identify dose-volume correlates with late swallowing disturbances. Study design, dose-volume data, toxicity evaluation, and statistical methods were considered in the analysis. RESULTS: Seven studies were found, among which one prospective study reported exact dose-volume correlates for individual swallowing structures. Four studies identified dose-volume correlates without reporting exact numbers. One study did not find any correlate of dose-volume data of the swallowing structures with late swallowing disturbances. Variations in patient characteristics, study design, methodology, and statistics made any comparison difficult. However, mean dose to the pharyngeus constrictor muscles appeared to be the most demonstrative predictor of late swallowing disturbances, e.g., reducing the mean dose to the pharyngeal constrictor muscles from 61-64 to 52-55 Gy resulted in fewer swallowing disturbances. There were no available data to estimate sensitivity, specificity, or predictive value of the reported dose-volume correlates. CONCLUSION: Mean dose to the pharyngeal constrictor muscles appeared to be the most important dosimetric predictor of late swallowing disturbances. Suggested dose-volume correlates require validation in prospective well-designed clinical trials, applying appropriate statistical methods that would account for possible interfering factors.
    Dysphagia 02/2013; 28(3). DOI:10.1007/s00455-013-9452-2 · 1.60 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: The number of oral cavity and oropharyngeal cancer survivors is rising. By 2030, oropharyngeal cancers are projected to account for almost half of all head and neck cancers. Normal speech, swallowing, and respiration can be disrupted by adverse effects of tumor and cancer therapy. This review summarizes clinically distinct functional outcomes of patients with oral cavity and oropharyngeal cancers, methods of pretreatment functional assessments, strategies to reduce or prevent functional complications, and posttreatment rehabilitation considerations.
    Otolaryngologic Clinics of North America 08/2013; 46(4):657-70. DOI:10.1016/j.otc.2013.04.006 · 1.34 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Emerging research suggests that preventative swallowing rehabilitation, undertaken before or during (chemo)radiotherapy ([C]RT), can significantly improve early swallowing outcomes for head and neck cancer (HNC) patients. However, these treatment protocols are highly variable. Determining specific physiological swallowing parameters that are most likely to be impacted post-(C)RT would assist in refining clear targets for preventative rehabilitation. Therefore, this systematic review (1) examined the frequency and prevalence of physiological swallowing deficits observed post-(C)RT for HNC, and (2) determined the patterns of prevalence of these key physiological deficits over time post-treatment. Online databases were searched for relevant papers published between January 1998 and March 2013. A total of 153 papers were identified and appraised for methodological quality and suitability based on exclusionary criteria. Ultimately, 19 publications met the study's inclusion criteria. Collation of reported prevalence of physiological swallowing deficits revealed reduced laryngeal excursion, base-of-tongue (BOT) dysfunction, reduced pharyngeal contraction, and impaired epiglottic movement as most frequently reported. BOT dysfunction and impaired epiglottic movement showed a collective prevalence of over 75 % in the majority of patient cohorts, whilst reduced laryngeal elevation and pharyngeal contraction had a prevalence of over 50 %. Subanalysis suggested a trend that the prevalence of these key deficits is dynamic although persistent over time. These findings can be used by clinicians to inform preventative intervention and support the use of specific, evidence-based therapy tasks explicitly selected to target the highly prevalent deficits post-(C)RT for HNC.
    Dysphagia 09/2013; 28(4). DOI:10.1007/s00455-013-9491-8 · 1.60 Impact Factor
Show more